Screener
Stryker SYK Enabling Technologies — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stryker in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Stryker’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 11:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000310764-26-000031
FAQ
- What is Stryker's enabling technologies — net sales?
- Stryker (SYK) reported enabling technologies — net sales of $26M in Q1 2026.
- What does enabling technologies — net sales mean?
- This metric represents the total revenue generated from the sale of advanced medical technology platforms, including robotic-assisted surgery systems, surgical navigation software, and digital imaging solutions. It reflects the company's ability to monetize high-tech capital equipment and associated recurring software or service contracts within the operating room environment. This segment is a critical driver of long-term growth as it creates a 'sticky' ecosystem that encourages the use of the company's proprietary implants and consumables.
Ask your AI about Stryker's enabling technologies — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude